L
Lisa4Catholics
Guest
Bergen County Chief Of Police Jack Schmidig leads Regional Roll-Out of VeriChip by Receiving a VeriChip
With Hospital Emergency Room Infrastructure To Provide Secure ID and Medical Record Access For VeriChip Patients, Thought and Opinion Leaders to Play Key Role in Adoption of VeriChip™
DELRAY BEACH, Fla.–(BUSINESS WIRE)–April 22, 2005-- VeriChip Corporation, a wholly-owned subsidiary of Applied Digital, announced today that the Bergen County, New Jersey Chief of Police has been implanted with the VeriChip. Chief of Police Jack Schmidig, a member of the police force for over 30 years, received a VeriChip as part of the Company’s strategy of enlisting key regional leaders to accelerate adoption of the VeriChip. With hospital emergency room infrastructure forming, patients will have the ability to provide secure ID and medical record access in an emergency or clinical situation.
“High-profile regional leaders are accepting the VeriChip, representing an excellent example of our approach to gaining adoption of the technology,” said Kevin H. McLaughlin, VeriChip Corporation’s CEO. “The northern New Jersey area represents one of our early regional targets, and in a short time period we have secured a leading hospital in the region which has agreed to adopt the VeriChip System to scan patients; initiated efforts to educate the physician community in conjunction with one of our distribution partners Henry Schein Corporation, and implanted several high-profile members of the community with the VeriChip. We intend to employ this approach on a regional basis to accelerate acceptance of this Class II medical device.”
VeriChip Corporation has adopted three key elements to its marketing strategy to develop regional acceptance for VeriChip. They include developing the infrastructure at regional hospitals to support the VeriChip System (scanner and database) in the Emergency Rooms; educating the medical community in the region in conjunction with Henry Schein and other distribution partners; and seeking high-profile members of the community to receive the VeriChip to raise awareness of the device.
Initially, the Company has identified several groups of patients that are likely to benefit from the VeriChip due to medical conditions. These include diabetics, chronic and cardiac care patients, memory impaired patients and patients with implanted medical devices. These patients would benefit from having a VeriChip as a result of medical conditions that increase the likelihood of an emergency room visit, which could require time-sensitive procedures where access to medical records would be critical.
Using the VeriChip System, the emergency room attendant could scan the VeriChip in the patient’s arm, accessing a unique 16-digit ID number. This number would be linked to a medical records database, which would provide detailed information on implanted medical devices and patient medical records, which could provide valuable information allowing the hospital to quickly implement the appropriate procedures on patients who otherwise might not be able to communicate medical histories due to impaired conditions.
With Hospital Emergency Room Infrastructure To Provide Secure ID and Medical Record Access For VeriChip Patients, Thought and Opinion Leaders to Play Key Role in Adoption of VeriChip™
DELRAY BEACH, Fla.–(BUSINESS WIRE)–April 22, 2005-- VeriChip Corporation, a wholly-owned subsidiary of Applied Digital, announced today that the Bergen County, New Jersey Chief of Police has been implanted with the VeriChip. Chief of Police Jack Schmidig, a member of the police force for over 30 years, received a VeriChip as part of the Company’s strategy of enlisting key regional leaders to accelerate adoption of the VeriChip. With hospital emergency room infrastructure forming, patients will have the ability to provide secure ID and medical record access in an emergency or clinical situation.
“High-profile regional leaders are accepting the VeriChip, representing an excellent example of our approach to gaining adoption of the technology,” said Kevin H. McLaughlin, VeriChip Corporation’s CEO. “The northern New Jersey area represents one of our early regional targets, and in a short time period we have secured a leading hospital in the region which has agreed to adopt the VeriChip System to scan patients; initiated efforts to educate the physician community in conjunction with one of our distribution partners Henry Schein Corporation, and implanted several high-profile members of the community with the VeriChip. We intend to employ this approach on a regional basis to accelerate acceptance of this Class II medical device.”
VeriChip Corporation has adopted three key elements to its marketing strategy to develop regional acceptance for VeriChip. They include developing the infrastructure at regional hospitals to support the VeriChip System (scanner and database) in the Emergency Rooms; educating the medical community in the region in conjunction with Henry Schein and other distribution partners; and seeking high-profile members of the community to receive the VeriChip to raise awareness of the device.
Initially, the Company has identified several groups of patients that are likely to benefit from the VeriChip due to medical conditions. These include diabetics, chronic and cardiac care patients, memory impaired patients and patients with implanted medical devices. These patients would benefit from having a VeriChip as a result of medical conditions that increase the likelihood of an emergency room visit, which could require time-sensitive procedures where access to medical records would be critical.
Using the VeriChip System, the emergency room attendant could scan the VeriChip in the patient’s arm, accessing a unique 16-digit ID number. This number would be linked to a medical records database, which would provide detailed information on implanted medical devices and patient medical records, which could provide valuable information allowing the hospital to quickly implement the appropriate procedures on patients who otherwise might not be able to communicate medical histories due to impaired conditions.